Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

DHEA did not improve sexual function, well-being, or menopausal symptoms in postmenopausal women with low libido but caused side effects like acne and increased facial hair.

Dietary changes, including weight loss and a balanced diet, are important for managing PCOS, especially in overweight women.

There's no significant link between the D19S884 marker at the insulin receptor gene and polycystic ovary syndrome.

Cytokines and neuropeptides are key in controlling androgen levels, affecting skin and hair conditions.

COVID-19 might affect male fertility, but more research is needed to understand the full impact.

The document concludes that understanding and treating hair loss requires recognizing its various types and using appropriate diagnostic tools and treatments.

The skin's ability to produce hormones is linked to various skin conditions, and better understanding this process could lead to new treatments.

Men with early hair loss have similar hormone levels to women with PCOS, possibly increasing risk of obesity and heart issues.

The research suggests that the global distribution of PCOS is likely due to historical human migration and that genes affecting PCOS may have different impacts on males and females.

The document concludes that research on sulfatase inhibitors should continue due to their potential in treating various diseases, despite some clinical trial failures.

Androgens significantly affect female hair loss, and hormonal treatments may help.

The document concludes that more research is needed to understand excessive hair growth in women with normal hormone levels and regular ovulation.

COVID-19 temporarily affects male reproductive health, but sperm and testosterone levels generally return to normal after three months.

Hormonal treatments are effective for severe or persistent acne and should be used with other acne therapies, considering potential side effects.

Insulin resistance is significantly linked to a higher risk of depression in women with PCOS.

Taking DHEA for a year is generally safe for postmenopausal women but may cause acne and more facial hair without improving metabolism or aging.

Testosterone therapy can help improve sexual desire and function in postmenopausal women but may cause side effects and is not FDA-approved for this use.

People with polycystic ovary syndrome may have a higher risk of heart problems due to abnormal nervous system control of their heart and blood pressure.

Birth control pills increase the risk of blood clots, especially within the first year and with certain types.

Testosterone and dihydrotestosterone affect hair growth, and new techniques like the folliculogram help study it, but fully understanding hair growth is still complex.

Melatonin improved mental health and metabolism in women with PCOS.

Testosterone therapy is generally safe for transmen, improves sexual function, and has manageable health risks with proper monitoring.

Women with PCOS are more likely to have fatty liver disease, especially if they have metabolic problems.

The conclusion is that androgen receptor gene polymorphism might be a marker for polycystic ovary syndrome, but more research is needed.

Obese women with PCOS are more likely to have fatty liver disease.

To diagnose Polycystic Ovarian Syndrome, two out of three signs—irregular periods, high male hormone levels, or cysts on the ovaries—are needed.

Finasteride for hair loss may cause long-lasting side effects like impotence and low libido, but trials lack proper safety reporting.

High levels of androgens during early development may cause PCOS-like symptoms.

Longer CAG repeat lengths in the androgen receptor gene are linked to higher testosterone levels in women with PCOS.

FAGA diagnosis uses blood tests and trichoscopy, with treatments like topical minoxidil, oral anti-androgens, and hormone-modulating drugs.